Jannine Versi
Direttore/Membro del Consiglio presso DMK PHARMACEUTICALS CORPORATION
Patrimonio netto: 159 $ in data 30/04/2024
Profilo
Jannine C.
A Versi was the founder of My Elektra, Inc. founded in 2019, where she held the title of Chief Operating Officer.
Currently, she is a Director at DMK Pharmaceuticals Corp.
since 2023.
Jannine's former job was as a Director at DMK Pharmaceuticals Corp.
(Old).
Jannine's education includes an undergraduate degree from the University of Pennsylvania and an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 06/10/2023 | 2 481 ( 0.02% ) | 89 $ | 30/04/2024 | |
| 06/10/2023 | 1 941 ( inf% ) | 70 $ | 30/04/2024 |
Posizioni attive di Jannine Versi
| Società | Posizione | Inizio |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Direttore/Membro del Consiglio | 25/05/2023 |
My Elektra, Inc.
 My Elektra, Inc. Internet Software/ServicesTechnology Services My Elektra, Inc. provides women to take hormonal health journey. The company was founded in 2019 by Alessandra Henderson and Jannine Versi and is headquartered in Brooklyn, NY. | Fondatore | 01/01/2019 |
Precedenti posizioni note di Jannine Versi
| Società | Posizione | Fine |
|---|---|---|
DMK Pharmaceuticals Corp. (Old)
 DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Direttore/Membro del Consiglio | - |
Formazione di Jannine Versi
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
My Elektra, Inc.
My Elektra, Inc. Internet Software/ServicesTechnology Services My Elektra, Inc. provides women to take hormonal health journey. The company was founded in 2019 by Alessandra Henderson and Jannine Versi and is headquartered in Brooklyn, NY. | Technology Services |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Health Technology |
- Borsa valori
- Insiders
- Jannine Versi
